Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92–100.
PubMed
Article
Google Scholar
Travin MI. Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol. 2013;20(1):128–43 (quiz 46).
PubMed
Article
Google Scholar
Yoshinaga K, Chow BJ, DeKemp RA, Thorn S, Ruddy TD, Davies RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des. 2005;11(7):903–32.
PubMed
Article
CAS
Google Scholar
Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med. 1991;325(9):656–7.
PubMed
Article
CAS
Google Scholar
Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39(1):113–9.
PubMed
Article
CAS
Google Scholar
Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol. 2011;18(1):135–43.
PubMed
Article
PubMed Central
Google Scholar
Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55(24):2769–77.
PubMed
Article
Google Scholar
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55(20):2212–21.
PubMed
Article
Google Scholar
Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol. 1998;5(6):579–90.
PubMed
Article
CAS
Google Scholar
Guidelines for clinical use of cardiac nuclear medicine (JCS 2010)—digest version. Circ J. 2012;76(3):761–7.
Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Improved quantification in 123I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun. 2006;27(7):551–8.
PubMed
Article
Google Scholar
Verberne HJ, Somsen GA, Povinec P, van Eck-Smit BL, Jacobson AF. Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging. 2009;36(8):1322–8.
PubMed
Article
PubMed Central
Google Scholar
Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med. 1995;36(6):969–74.
PubMed
CAS
Google Scholar
Ji SY, Travin MI. Radionuclide imaging of cardiac autonomic innervation. J Nucl Cardiol. 2010;17(4):655–66.
PubMed
Article
Google Scholar
Segall GM, Davis MJ. Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior wall defects. J Nucl Med. 1989;30(4):548–55.
PubMed
CAS
Google Scholar
Nishina H, Slomka PJ, Abidov A, Yoda S, Akincioglu C, Kang X, et al. Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease. J Nucl Med. 2006;47(1):51–8.
PubMed
Google Scholar
Lautamaki R, Tipre D, Bengel FM. Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging. 2007;34(Suppl 1):S74–85.
PubMed
Article
CAS
Google Scholar
Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82(2):457–64.
PubMed
Article
CAS
Google Scholar
Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300(24):1350–8.
PubMed
Article
CAS
Google Scholar
Mabuchi M, Imamura M, Kubo N, Morita K, Noriyasu K, Tsukamoto T, et al. Sympathetic denervation and reinnervation after the maze procedure. J Nucl Med. 2005;46(7):1089–94.
PubMed
Google Scholar
Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3(5):595–603.
PubMed
Article
Google Scholar
Hayes SW, De Lorenzo A, Hachamovitch R, Dhar SC, Hsu P, Cohen I, et al. Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT. J Nucl Med. 2003;44(10):1633–40.
PubMed
Google Scholar
Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med. 1990;31(8):1328–34.
PubMed
CAS
Google Scholar
Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993;22(2):368–75.
PubMed
Article
CAS
Google Scholar
Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006;13(6):e121–51.
PubMed
Article
Google Scholar
Yoshinaga K, Chow BJ, Williams K, Chen L, DeKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48(5):1029–39.
PubMed
Article
Google Scholar
Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation. 2000;101(22):2579–85.
PubMed
Article
CAS
Google Scholar
Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K, Nakajima K, et al. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Nucl Med. 2002;43(1):15–20.
PubMed
CAS
Google Scholar
Chen W, Cao Q, Dilsizian V. Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep. 2011;13(2):132–7.
PubMed
Article
Google Scholar
Kiat H, Van Train KF, Friedman JD, Germano G, Silagan G, Wang FP, et al. Quantitative stress-redistribution thallium-201 SPECT using prone imaging: methodologic development and validation. J Nucl Med. 1992;33(8):1509–15.
PubMed
CAS
Google Scholar
Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation. 1999;99(21):2742–9.
PubMed
Article
CAS
Google Scholar